Litcius/Paper detail

Three-month outcomes of treatment with faricimab or aflibercept for neovascular age-related macular degeneration: a propensity score matching study in a Japanese population

Yosuke Fukuda, Shoji Notomi, Satomi Shiose, Yusuke Maehara, Kohei Kiyohara, Kohta Fujiwara, Sawako Hashimoto, Kumiko Kano, Keijiro Ishikawa, Toshio Hisatomi, Koh-Hei Sonoda

2024Graefe s Archive for Clinical and Experimental Ophthalmology14 citationsDOI

Topics & Concepts

AfliberceptMacular degenerationMedicinePropensity score matchingChoroidal neovascularizationOphthalmologyVisual acuityBevacizumabClinical endpointRanibizumabRandomized controlled trialSurgeryChemotherapyRetinal Diseases and TreatmentsOphthalmology and Visual Impairment StudiesOcular Diseases and Behçet’s Syndrome
Three-month outcomes of treatment with faricimab or aflibercept for neovascular age-related macular degeneration: a propensity score matching study in a Japanese population | Litcius